These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


240 related items for PubMed ID: 21059087

  • 1. Ability of cystatin C to detect acute changes in glomerular filtration rate provoked by hyperglycaemia in uncomplicated Type 1 diabetes.
    Cherney DZ, Sochett EB, Dekker MG, Perkins BA.
    Diabet Med; 2010 Dec; 27(12):1358-65. PubMed ID: 21059087
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy.
    Christensson AG, Grubb AO, Nilsson JA, Norrgren K, Sterner G, Sundkvist G.
    J Intern Med; 2004 Dec; 256(6):510-8. PubMed ID: 15554952
    [Abstract] [Full Text] [Related]

  • 5. Cystatin C does not detect acute changes in glomerular filtration rate in early diabetic nephropathy.
    Mueller TF, Raeder J, Oettl K, Zitta S, Klausmann G, Estelberger W, Luyckx VA, Reibnegger G.
    Ren Fail; 2008 Dec; 30(1):21-9. PubMed ID: 18197539
    [Abstract] [Full Text] [Related]

  • 6. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes.
    Oddoze C, Morange S, Portugal H, Berland Y, Dussol B.
    Am J Kidney Dis; 2001 Aug; 38(2):310-6. PubMed ID: 11479157
    [Abstract] [Full Text] [Related]

  • 7. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate.
    Hoek FJ, Kemperman FA, Krediet RT.
    Nephrol Dial Transplant; 2003 Oct; 18(10):2024-31. PubMed ID: 13679476
    [Abstract] [Full Text] [Related]

  • 8. Cystatin C improves the diagnosis and stratification of chronic kidney disease, and the estimation of glomerular filtration rate in diabetes.
    Rigalleau V, Beauvieux MC, Le Moigne F, Lasseur C, Chauveau P, Raffaitin C, Perlemoine C, Barthe N, Combe C, Gin H.
    Diabetes Metab; 2008 Nov; 34(5):482-9. PubMed ID: 18703370
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic accuracy of various glomerular filtration rates estimating equations in patients with chronic kidney disease and diabetes.
    Li HX, Xu GB, Wang XJ, Zhang XC, Yang JM.
    Chin Med J (Engl); 2010 Mar 20; 123(6):745-51. PubMed ID: 20368098
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Usefulness of serum cystatin C in Japanese patients with type 2 diabetes mellitus and nephropathy.
    Kimura T, Ikeda H, Fujikawa J, Nomura K, Aoyama T, Wada Y, Nabe K, Hamamoto Y, Honjo S, Koshiyama H.
    Diabetes Res Clin Pract; 2009 Feb 20; 83(2):e58-61. PubMed ID: 19118914
    [Abstract] [Full Text] [Related]

  • 13. Validation of a new plasma cystatin C-based formula and the Modification of Diet in Renal Disease creatinine-based formula for determination of glomerular filtration rate.
    Sterner G, Björk J, Carlson J, Grubb A, Nyman U.
    Scand J Urol Nephrol; 2009 Feb 20; 43(3):242-9. PubMed ID: 19291590
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The comparison of cystatin C and creatinine as an accurate serum marker in the prediction of type 2 diabetic nephropathy.
    Lee BW, Ihm SH, Choi MG, Yoo HJ.
    Diabetes Res Clin Pract; 2007 Dec 20; 78(3):428-34. PubMed ID: 17822797
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Serum cystatin C predicts progression of subclinical coronary atherosclerosis in individuals with type 1 diabetes.
    Maahs DM, Ogden LG, Kretowski A, Snell-Bergeon JK, Kinney GL, Berl T, Rewers M.
    Diabetes; 2007 Nov 20; 56(11):2774-9. PubMed ID: 17660266
    [Abstract] [Full Text] [Related]

  • 18. Serum cystatin C in diabetic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy.
    Ogawa Y, Goto T, Tamasawa N, Matsui J, Tando Y, Sugimoto K, Tomotsune K, Kimura M, Yasujima M, Suda T.
    Diabetes Res Clin Pract; 2008 Feb 20; 79(2):357-61. PubMed ID: 17980929
    [Abstract] [Full Text] [Related]

  • 19. Cystatin C-based equations in renal transplantation: moving toward a better glomerular filtration rate prediction?
    Maillard N, Mariat C, Bonneau C, Mehdi M, Thibaudin L, Laporte S, Alamartine E, Chamson A, Berthoux F.
    Transplantation; 2008 Jun 27; 85(12):1855-8. PubMed ID: 18580481
    [Abstract] [Full Text] [Related]

  • 20. Serum cystatin C versus serum creatinine in the estimation of glomerular filtration rate in rhabdomyolysis.
    Yap M, Lamarche J, Peguero A, Courville C.
    J Ren Care; 2011 Sep 27; 37(3):155-7. PubMed ID: 21810197
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.